Annual ROE
-6.30%
+1.72%+21.45%
December 31, 2023
Summary
- As of February 10, 2025, MACK annual return on equity is -6.30%, with the most recent change of +1.72% (+21.45%) on December 31, 2023.
- During the last 3 years, MACK annual ROE has risen by +12.62% (+66.70%).
Performance
MACK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
288.18%
+294.42%+4718.27%
March 1, 2024
Summary
- As of February 10, 2025, MACK quarterly return on equity is 288.18%, with the most recent change of +294.42% (+4718.27%) on March 1, 2024.
- Over the past year, MACK quarterly ROE has increased by +295.70% (+3932.18%).
Performance
MACK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MACK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.4% | +3932.2% |
| 3 y3 years | +66.7% | +3932.2% |
| 5 y5 years | +90.8% | +3932.2% |
MACK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +174.6% | at high | -105.7% |
| 5 y | 5-year | at high | +1489.2% | at high | -119.0% |
| alltime | all time | -100.4% | +1489.2% | -94.1% | -2018.8% |
Merrimack Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | 288.18%(-4718.3%) |
| Dec 2023 | -6.30%(-21.4%) | -6.24%(-17.0%) |
| Sep 2023 | - | -7.52%(-16.8%) |
| Jun 2023 | - | -9.04%(-12.4%) |
| Mar 2023 | - | -10.32%(+0.5%) |
| Dec 2022 | -8.02%(-53.6%) | -10.27%(-7.4%) |
| Sep 2022 | - | -11.09%(-2.7%) |
| Jun 2022 | - | -11.40%(-12.6%) |
| Mar 2022 | - | -13.05%(-20.7%) |
| Dec 2021 | -17.30%(-8.6%) | -16.46%(-18.1%) |
| Sep 2021 | - | -20.09%(-10.5%) |
| Jun 2021 | - | -22.45%(-7.0%) |
| Mar 2021 | - | -24.13%(+35.7%) |
| Dec 2020 | -18.92%(-81.1%) | -17.78%(-330.3%) |
| Sep 2020 | - | 7.72%(-14.4%) |
| Jun 2020 | - | 9.02%(-132.5%) |
| Mar 2020 | - | -27.75%(-49.4%) |
| Dec 2019 | -100.12%(+45.4%) | -54.84%(-22.1%) |
| Sep 2019 | - | -70.36%(+52.1%) |
| Jun 2019 | - | -46.25%(-17.4%) |
| Mar 2019 | - | -55.98%(-7.6%) |
| Dec 2018 | -68.87%(-114.0%) | -60.59%(+3.7%) |
| Sep 2018 | - | -58.41%(+12.4%) |
| Jun 2018 | - | -51.97%(-110.6%) |
| Mar 2018 | - | 491.70%(-89.9%) |
| Dec 2017 | 490.25% | 4880.36%(-932.3%) |
| Sep 2017 | - | -586.34%(+126.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | -259.21%(-533.0%) |
| Mar 2017 | - | 59.87%(-11.6%) |
| Dec 2016 | 60.43%(-24.9%) | 67.70%(-16.0%) |
| Sep 2016 | - | 80.60%(-16.6%) |
| Jun 2016 | - | 96.62%(+9.2%) |
| Mar 2016 | - | 88.49%(-10.6%) |
| Dec 2015 | 80.44%(-1.4%) | 99.03%(+16.3%) |
| Sep 2015 | - | 85.16%(+6.2%) |
| Jun 2015 | - | 80.21%(-9.5%) |
| Mar 2015 | - | 88.65%(-8.2%) |
| Dec 2014 | 81.55%(-72.9%) | 96.59%(-35.2%) |
| Sep 2014 | - | 149.03%(-36.2%) |
| Jun 2014 | - | 233.50%(-17.7%) |
| Mar 2014 | - | 283.71%(-18.8%) |
| Dec 2013 | 301.22%(-78.5%) | 349.38%(-19.6%) |
| Sep 2013 | - | 434.32%(-14.2%) |
| Jun 2013 | - | 506.41%(-109.2%) |
| Mar 2013 | - | -5529.60%(-4238.6%) |
| Dec 2012 | 1400.60%(+293.6%) | 133.61%(+14.1%) |
| Sep 2012 | - | 117.12%(+111.0%) |
| Jun 2012 | - | 55.52%(+35.2%) |
| Mar 2012 | - | 41.06%(+2.0%) |
| Dec 2011 | 355.82%(+1462.0%) | 40.24%(+39.2%) |
| Sep 2011 | - | 28.91%(+3.3%) |
| Jun 2011 | - | 27.99%(+25.3%) |
| Mar 2011 | - | 22.33%(-2.0%) |
| Dec 2010 | 22.78%(-11.4%) | 22.78% |
| Dec 2009 | 25.72% | - |
FAQ
- What is Merrimack Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual ROE year-on-year change?
- What is Merrimack Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly ROE year-on-year change?
What is Merrimack Pharmaceuticals annual return on equity?
The current annual ROE of MACK is -6.30%
What is the all time high annual ROE for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual return on equity is 1400.60%
What is Merrimack Pharmaceuticals annual ROE year-on-year change?
Over the past year, MACK annual return on equity has changed by +1.72% (+21.45%)
What is Merrimack Pharmaceuticals quarterly return on equity?
The current quarterly ROE of MACK is 288.18%
What is the all time high quarterly ROE for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly return on equity is 4880.36%
What is Merrimack Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, MACK quarterly return on equity has changed by +295.70% (+3932.18%)